Evidence map›Paper›PMID 33948951›Full record

ArticleVeterinary surgery : VS2021

Influence of a novel scaffold composed of polyurethane, hydroxyapatite, and decellularized bone particles on the healing of fourth metacarpal defects in mares.

Remigiusz M Grzeskowiak, Karrer M Alghazali, Silke Hecht, Robert L Donnell, Thomas J Doherty, Christopher K Smith, David E Anderson, Alexandru S Biris, Henry S Adair

Open access · hybridAbstract read
In one paragraph

Article in Veterinary surgery : VS, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. The effect of green synthesis of TiOVeterinary medicine and science · 2023
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Remigiusz M GrzeskowiakDepartment of Large Animal Clinical Sciences, The University of Tennessee College of Veterinary Medicine, Knoxville, Tennessee, USA.ORCID https://orcid.org/0000-0002-8656-5162
Karrer M AlghazaliCenter for Integrative Nanotechnology Sciences, University of Arkansas at Little Rock, Little Rock, Arkansas, USA.
Silke HechtDepartment of Small Animal Clinical Sciences, The University of Tennessee College of Veterinary Medicine, Knoxville, Tennessee, USA.ORCID https://orcid.org/0000-0001-8805-836X
Robert L DonnellDepartment of Biomedical and Diagnostic Sciences, The University of Tennessee College of Veterinary Medicine, Knoxville, Tennessee, USA.ORCID https://orcid.org/0000-0002-6778-954X
Thomas J DohertyDepartment of Large Animal Clinical Sciences, The University of Tennessee College of Veterinary Medicine, Knoxville, Tennessee, USA.ORCID https://orcid.org/0000-0002-5617-1138
Christopher K SmithDepartment of Small Animal Clinical Sciences, The University of Tennessee College of Veterinary Medicine, Knoxville, Tennessee, USA.
David E AndersonDepartment of Large Animal Clinical Sciences, The University of Tennessee College of Veterinary Medicine, Knoxville, Tennessee, USA.ORCID https://orcid.org/0000-0003-0745-7591
Alexandru S BirisCenter for Integrative Nanotechnology Sciences, University of Arkansas at Little Rock, Little Rock, Arkansas, USA.
Henry S AdairDepartment of Large Animal Clinical Sciences, The University of Tennessee College of Veterinary Medicine, Knoxville, Tennessee, USA.ORCID https://orcid.org/0000-0001-7458-9071
Knoxville College · USUniversity of Arkansas at Little Rock · USUniversity of Tennessee at Knoxville · US

Funding

Karen Gilhousen Equine Bone Regeneration Fund, Department of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Tennessee.
6 · The paper itself

Abstract

objectiveTo determine the effect of a novel scaffold, designed for use in bone regeneration, on healing of splint bone segmental defects in mares. STUDY

designIn vivo experimental study. SAMPLE POPULATION: Five adult mares (4-10 years old; mean weight, 437.7 kg ± 29 kg).

methodsBilateral 2-cm full-thickness defects were created in the fourth metacarpal bones (MCIV) of each horse. Each defect was randomly assigned to either a novel scaffold treatment (n = 5) or an untreated control (n = 5). The scaffold was composed of polyurethane, hydroxyapatite, and decellularized bone particles. Bone healing was assessed for a period of 60 days by thermography, ultrasonography, radiography, and computed tomography (CT). Biopsies of each defect were performed 60 days after surgery for histological evaluation.

resultsOn the basis of radiographic analysis, scaffold-treated defects had greater filling (67.42% ± 26.7%) compared with untreated defects (35.88% ± 32.7%; P = .006). After 60 days, CT revealed that the density of the defects treated with the scaffolds (807.80 ± 129.6 Hounsfield units [HU]) was greater than density of the untreated defects (464.80 ± 81.3 HU; P = .004). Evaluation of histology slides provided evidence of bone formation within an average of 9.43% ± 3.7% of the cross-sectional area of scaffolds in contrast to unfilled defects in which connective tissue was predominant throughout the biopsy specimens.

conclusionThe novel scaffold was biocompatible and supported bone formation within the MCIV segmental defects. CLINICAL SIGNIFICANCE: This novel scaffold offers an effective option for filling bone voids in horses when support of bone healing is indicated.

Indexed as

DurapatitePolyurethanesAnimalsBiocompatible MaterialsBone and BonesBone RegenerationFemaleGuided Tissue RegenerationHorse DiseasesHorsesMetacarpal BonesTissue ScaffoldsWound HealingBiocompatible MaterialsDurapatitePolyurethanes

Identifiers

PMID33948951
PMCPMC8360067
OpenAlexW3157585098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.